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ABSTRACT
Eustachian valve endocarditis (EVE) is a distinctly rare and underdiagnosed entity. We report 2 new cases caused 
by vancomycin resistant Staphylococcus aureus and Staphylococcus hominis diagnosed on transesophageal 
echocardiography (TEE). Although, 63% of Eustachian valve endocarditis is caused by Staphylococcus aureus, 
we report the first case of vancomycin resistant Staphylococcus aureus and first case related to implantable 
venous access systems. EVE is now seen more commonly in elderly population with diverse microbial cultures 
and antibiotic sensitivities. TTE is the first modality for investigation of EVE, however a negative TTE does 
not preclude the diagnosis, as only 88% of cases were diagnosed on TEE. 
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INTRODUCTION
Right sided valvular involvement in infective endocarditis has 
been well-described, but lesions affecting Eustachian valve 
are distinctly rare. In 1986, Edwards et al.[1] first described 
the entity of Eustachian valve endocarditis (EVE) in an 
autopsy study of a patient with overwhelming streptococcal 
sepsis. In the literature only few cases have been reported 
so far. Herein, we review the literature and describe 2 new 
cases in which the causative organisms were determined to 
be vancomycin resistant Staphylococcus aureus (VRSA), which 
is reported for the first time, and Staphylococcus hominis.
CASE REPORTS
Case 1
A 33 year old woman with a history of intravenous 
drug use was admitted with a history of fever, chills 
and cough for the last 4 days. On presentation, she was 
noted to have a temperature of 102.4 F (reference range   
96.8-100.4 F), an elevated pulse rate (110 bpm) (reference 
range 55-90 bpm), respiration rate of 26 breaths/min 
(reference range 12-20 breaths/min) and low blood 
pressure (90/50 mm Hg) (reference range 100-139/55-
84 mm Hg). Blood investigation showed an elevated 
white blood cell count (22,600 cells/µL) (reference range 
4000-11000 cells/µL). Chest radiography demonstrated 
bilateral multiple cavitatory nodules consistent with 
septic emboli. Suboptimal images by transthoracic 
echocardiography (TTE) showed mobile vegetation 
on the tricuspid valve, along with severe tricuspid 
regurgitation. Eustachian valve was not visualized. 
Transesophageal echocardiography (TEE) revealed a 
6-cm, echogenic mass attached to the eustachian valve,   
[Figures 1 and 2] along with pulmonary valve and right 
ventricular wall. During the next 2 days, the patient’s 
condition was complicated by hemoptysis, renal failure 
and hypoxic respiratory failure requiring mechanical 
ventilation.
She received empiric antibiotic therapy with vancomycin, 
gentamicin and rifampin. Three blood cultures grew 
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vancomycin resistant Staphylococcus aureus (VRSA). She 
was treated with intravenous daptomycin initially with   
6 mg/kg every 24 hours, and was discharged after   
4 weeks of antibiotics.
Case 2
A 86-year-old nursing home female with a history of 
dementia, severe aortic stenosis, congestive heart failure, 
chronic anemia secondary to gastrointestinal bleeding 
requiring implantable venous catheter insertion, presented 
with high grade temperature of 1030F (reference range 
96.8-100.4 F) rectally, pulse rate of 124bpm (reference 
range 55-90 bpm), respiration rate of 23 breaths/min 
(reference range 12-20 breaths/min) and blood pressure 
of 128/69 mm Hg (reference range 100-139/55-84 mm 
Hg). Laboratory data showed an elevated white blood 
count 30,000 cells/µL (86% polymorphs) (reference 
range 4000-11000 cells/µL), low hemoglobin of 7.1 g/
dl (reference range 14.0-18.0 g/dl) and normal platelets 
(323,000/µl) (reference range 150,000-450,000/µl) 
Physical examination revealed a thin, cachectic female 
with a late peaking systolic murmur at the left sternal 
border, a soft S2 and few scattered rhonchi all over the 
lungs. Blood cultures grew Staphylococcus  hominis resistant 
to penicillin G and sensitive to vancomycin. 
TTE revealed moderate concentric left ventricular 
hypertrophy with ejection fraction of 70%, a heavily 
calcified aortic valve with severe aortic stenosis and 
moderate pulmonary hypertension; however, no 
vegetations were identified. The TEE revealed a 2 cm 
mass attached to the Eustachian valve. The patient received 
4 weeks of vancomycin, 30 mg/kg in divided doses every 
24 hours and became afebrile with second set of blood 
culture turning negative.
DISCUSSION
Eustachian valve is an embryological remnant of the sinus 
venosus, directing oxygenated fetal blood from inferior 
vena cava across foramen ovale, and into the left atrium. 
In adults, it is non-functional and is considered a benign 
rudimentary structure. 
We present 2 new cases of EVE with a review of literature 
[Table 1]. In the previously reported cases, the age of 
patients ranged from 22 years to 76 years with a median 
age of 44.2 years, with a male to female ratio of 5:3. There 
seems to be an increasing trend in elderly population. In 
the present study, the age of the patients was 33 years and 
86 years. The incidence of EVE is not well documented; 
however, a retrospective review by San Roman et al.[2] 
reported an incidence of 3.3% in patients with right sided 
endocarditis. 
A predisposing factor was present in all but three cases,[3-5] 
with intravenous drug use (40% of the cases) being the 
most common. Other predisposing factors were presence 
of indwelling catheters, insertion of pacemaker wires, 
a history of rheumatic heart disease, and immunologic 
compromise (chronic alcoholism, human immunodeficiency   
virus – [HIV]) status. The increasing prevalence of 
indwelling catheters/devices may be the reason for 
increasing incidence of EVE in the elderly population. In 
the present study, a history of intravenous drug use was 
obtained in one case, and insertion of implantable venous 
catheter for repeated blood transfusions in the other case. 
The blood culture revealed Staphylococcus aureus to be 
the most common pathogenic organism in 53% of the 
cases, which is consistent with previous reviews Sawhney   
et al.[6] The association of Staphylococcus aureus positivity 
on blood cultures with intravenous drug abuse (IVDA) 
Figure 1: Transesophageal echocardiography image demonstrating 
a large vegetation (6 cm) attached to the Eustachian valve (Case 1)
VEGE: Vegetation, IVC: Inferior vena cava. 
Figure 2: Transesophageal echocardiographic image of vegetation 
attached to the right ventricular wall (Case 1)
Pulmonary ARY: Pulmonary artery.183 Journal of Cardiovascular Disease Research Vol. 2 / No 3
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Table 1: Summary of reported cases of Eustachian value endocarditis, their location, microbial agents involved,  
and prognosis
Study Age Sex Echocardiographic findings Predisposing 
factor









Case 1 33 F Tricuspid Trivial MR IVDA VRSA 0 + D/C














33 M 0 Trivial TR IVDA Staphylococcus 
aureus
0 + Pleural 
effusion





36 M 0 0 IVDA 0 + D/C
James et al.[8] 75 F 0 0 Pacemaker Enterobacter cloacae 0 + D/C








No growth + + D/C
Sawhney  
et al.[6]
32 F 0 0 Indwelling central 
Venous Catheter
Escherichia coli 0 + D/C





Proteus vulgaris 0 + D/C
39 F 0 0 IVDA Staphylococcus 
aureus
0 + D/C





San Roman  
et al.[2]
22 M Tricuspid, Mitral - IVDA, HIV Staphylococcus 
aureus
0 + D/C
25 M Tricuspid - IVDA Staphylococcus 
aureus
0 + D/C















23 M 0 - IVDA Staphylococcus 
aureus
0 + D/C
Bowers et al.[15] 36 F Tricuspid Severe TR IVDA Staphylococcus 
aureus






Schmidt et al.[4] 76 M 0 0 0 Streptococcus 
viridians
- - D/C
Gill et al.[3] 74 F 0 0 Absent Staphylococcus 
aureus
0 + Digital 
infarcts
Wong et al.[9] 70 F 0 Moderate 
MR













29 F 0 Severe TR IVDA Actinomyces israeli + + Surgical 
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Table 1: Contd...
Study Age Sex Echocardiographic findings Predisposing 
factor














52 M Pulmona-Ry 
artery









Chu et al.[18] 23 wks 
gestation






+ - Death of 
the neonate
AICD: Automatic implantable cardioverter defibrillator, AF: Atrial fibrillation, CABG: Coronary artery bypass grafting, *D/C- Discharged without complication, HIV: Human 
immunodeficiency virus, IVDA: Intravenous drug abuse, LA: Left atrium, MR: Mitral regurgitation, RA: Right atrium, TR: Tricuspid regurgitation, VRSA: Vancomycin resistant 
staphylococcus aureus 
and indwelling catheters was found to be in 100% of 
the cases. Other organisms that have been reported so 
far include Staphylococcus hominis,[7] Enterococcus cloacae,[8] 
Escherichia coli,[6] Proteus vulgaris,[6] Streptococcus viridans,[4] 
Klebsiella pneumonia[9,10] and Actinomyces israeli.[11] In our 
present report, the microorganisms isolated on blood 
cultures were VRSA and Staphylococcus hominis. This is the 
first case of VRSA EVE reported in the literature. In the 
second case, Staphylococcus hominis, a harmless commensal 
on human skin was the causative organism, likely related 
to the implantable venous access catheter insertion 
for chemotherapy (which is reported for the first time 
also). Like many other coagulase-negative Staphylococci, 
Staphylococcus hominis may occasionally cause infection in 
patients with compromised immune system.
Both cases in our series were detected on multi-planar 
TEE. The vegetations were not seen on TTE. The finding 
was in concordance with previous studies in which the 
vegetations were seen more frequently on TEE than 
TTE.[6] As the eustachian valve is situated posteriorly, the 
superiority of TEE over TTE is seen frequently.[12] Only 
in reports by Punzo et al.[13] and Navarro et al.[7] were TTE 
conclusive for EVE. In 2 other cases reported by Georgeson   
et al.,[14] TTE was frankly misleading, suggesting a ruptured 
chordae tendinae in one patient, and Chiari’s network in 
the other. TEE allows not only better visualization of 
the Eustachian valve and Chiari network, but also easily 
differentiates pathological masses from these normal 
structures. Nevertheless, TTE remains the first imaging 
investigation of choice; and, TEE should be performed 
if clinical picture strongly suggests endocarditis and no 
lesions are identified on TTE. 
Though EVE was first described in a post-mortem 
autopsy case, EVE seems to follow a benign clinical course 
presenting as right sided endocarditis, resolving with a 4-6 
week course of culture sensitive antibiotics, as seen in 78% 
of patients described till date. Few patients had a transient 
worsening of symptoms requiring intubation, open heart 
surgery with removal of Eustachian valve.
CONCLUSION
Endocarditis of Eustachian valve is a rare and under 
diagnosed entity. It should be strongly considered 
when a patient has the clinical syndrome of right-sided 
endocarditis, but no vegetations are identified on TTE. 
We found the incidence of EVE to be highest in young 
intra-venous drug users, and Staphylococcus aureus to be the 
most common microbial agent. However, over the past 6 
years EVE has been seen more frequently in the elderly 
population with culture positivity for diverse microbial 
agents. Multiplanar TEE remains the diagnostic tool of 
choice for detecting vegetations of Eustachian valve. 
Although EVE is rare, it may be unwise to rule out this 
diagnosis based solely on TTE, especially in the setting of 
persistent bacteremia or pulmonary emboli.[18]
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